91ֱ��

All publications

Journal articles

• Al-janabi H, Moyes K, Allen R, Fisher M, Crespo M, Gurel B, Rescigno P, de Bono J, Nunns H, Bailey C , Junker-Jensen A et al (2024) . Journal for ImmunoTherapy of Cancer, 12(7), e009368-e009368.
• Rahman MM, Wells G, Rantala JK, Helleday T, Muthana M & Danson SJ (2024) . Expert Review of Clinical Immunology.
• Kwan A, Stark K, Allen R, Ottewell P & Muthana M (2024) . Medical Research Archives, 12(6).
• Hapuarachi B, Danson S, Wadsley J & Muthana M (2023) . Frontiers in Immunology, 14, 1335256.
• Egerton K, Mitchell TA, Gravells P, Katse R, Fisher M, Muthana M, Eyers CE, Eyers PA & Bryant HE (2023) . ESMO Open, 8(1), 101664-101664.
• Patel P, Alghamdi A, Shaw G, Legge C, Glover M, Freeman D, Hodgetts H, Wilson E, Howard F, Staniland S , Kennerley AJ et al (2023) . Nanotheranostics, 7(1), 102-116.
• Winder N, Gohar S & Muthana M (2022) . Viruses, 14(12).
• Howard FHN, Al‐Janabi H, Patel P, Cox K, Smith E, Vadakekolathu J, Pockley AG, Conner J, Nohl JF, Allwood DA , Collado‐Rojas C et al (2022) . Small.
• Kim T, Johnston J, Castillo-Lluva S, Cimas FJ, Hamby S, Gonzalez-Moreno S, Villarejo-Campos P, Goodall AH, Velasco G, Ocana A , Muthana M et al (2022) . Theranostics, 12(8), 3584-3600.
• Iscaro A, Jones C, Forbes N, Mughal A, Howard FN, Janabi HA, Demiral S, Perrie Y, Essand M, Weglarz A , Cruz LJ et al (2022) . Nanomedicine: Nanotechnology, Biology and Medicine, 40.
• Canuas-Landero VG, George CN, Lefley DV, Corness H, Muthana M, Wilson C & Ottewell PD (2021) . Frontiers in Endocrinology, 12.
• Kwan A, Winder N & Muthana M (2021) . Viruses, 13(6).
• George C, Lefley D, Canuas-Landero V, Tulotta C, Corness H, Wilson C, Muthana M & Ottewell P (2021) . Bone Reports, 14, 101024.
• Taher Z, Legge C, Winder N, Lysyganicz P, Rawlings A, Bryant H, Muthana M & Staniland S (2021) . Pharmaceutics, 13(3).
• Müller LME, Migneco G, Scott GB, Down J, King S, Askar B, Jennings V, Oyajobi B, Scott K, West E , Ralph C et al (2021) . Journal for ImmunoTherapy of Cancer, 9(3).
• Deng S, Iscaro A, Zambito G, Mijiti Y, Minicucci M, Essand M, Lowik C, Muthana M, Censi R, Mezzanotte L & Di Martino P (2021) . Nanomaterials, 11(1).
• Sier VQ, de Vries MR, van der Vorst JR, Vahrmeijer AL, van Kooten C, Cruz LJ, de Geus-Oei L-F, Ferreira V, Sier CFM, Alves F & Muthana M (2021) . International Journal of Molecular Sciences, 22(2).
• Aldughaim MS, Muthana M, Alsaffar F & Barker MD (2021) . Molecules, 26(1).
• George CN, Canuas-Landero V, Theodoulou E, Muthana M, Wilson C & Ottewell P (2020) . Journal of Bone Oncology, 25.
• Howard F & Muthana M (2020) . Nanomedicine, 15(1), 93-110.
• Niespolo C, Shologu Z, Satam S, Iscaro A, Muthana M, Socorro S, Wilson HL & Kiss-Toth E (2019) . European Urology Supplements, 18(8), e3090-e3091.
• Narayanan P, Martinez Campesino L, Kim T, Muthana M, Wilson HL & Kiss-Toth E (2019) . European Urology Supplements, 18(8), e3060-e3060.
• Iscaro A, Howard NF & Muthana M (2019) . Current Pharmaceutical Design, 25(17), 1962-1979.
• Dorris ER, Tazzyman SJ, Moylett J, Ramamoorthi N, Hackney J, Townsend M, Muthana M, Lewis MJ, Pitzalis C & Wilson AG (2019) . The Journal of Immunology, 202(4), 1069-1078.
• Song W, Gregory DA, Al-janabi H, Muthana M, Cai Z & Zhao X (2019) . International Journal of Pharmaceutics, 555, 322-336.
• Stewart GR, Tazzyman S, Lath D, Down J, Snowden JA, Lawson M, Muthana M & Chantry AD (2018) . Blood, 132(Supplement 1), 3213-3213.
• Song W, Muthana M, Mukherjee J, Falconer RJ, Biggs CA & Zhao X (2017) . ACS Biomaterials Science & Engineering, 3(6), 1027-1038.
• Rahat MA, Coffelt SB, Granot Z, Muthana M & Amedei A (2016) . Mediators Inflamm, 2016, 5894347-5894347.
• Colley HE, Muthana M, Danson SJ, Jackson LV, Brett ML, Harrison J, Coole SF, Mason DP, Jennings LR, Wong M , Tulasi V et al (2015) . Journal of Medicinal Chemistry, 58(23), 9309-9333.
• Hawtree S, Muthana M, Wilkinson JM, Akil M & Wilson AG (2015) . Human Molecular Genetics, 24(19), 5367-5377.
• Muthana M, Hawtree S, Wilshaw A, Linehan E, Roberts H, Khetan S, Adeleke G, Wright F, Akil M, Fearon U , Veale D et al (2015) . Proceedings of the National Academy of Sciences, 112(37), 11618-11623.
• Hughes R, Qian B-Z, Rowan C, Muthana M, Keklikoglou I, Olson OC, Tazzyman S, Danson S, Addison C, Clemons M , Gonzalez-Angulo AM et al (2015) . Cancer Research, 75(17), 3479-3491.
• Muthana M, Kennerley AJ, Hughes R, Faganano E, Richardson J, Paul M, Murdoch C, Wright F, Payne C, Lythgoe MF , Farrow N et al (2015) . Nature Communications, 6(-), ---.
• Hawtree S, Muthana M, Wilkinson JM & Wilson AG (2014) . Rheumatology, 53(suppl_1), i85-i85.
• Ellam T, Hameed A, ul Haque R, Muthana M, Wilkie M, Francis SE & Chico TJA (2014) . PLoS One, 9(2), e88767.
• Chen Y-Y, Brown NJ, Jones R, Lewis CE, Mujamammi AH, Muthana M, Seed MP & Barker MD (2014) . Angiogenesis, 17(1), 207-219.
• Hawtree S, Muthana M, Aynsley S, Wilkinson JM & Wilson AG (2013) . Annals of the Rheumatic Diseases, 72(Suppl 3), A165.4-A166.
• Hardy WJ, Aynsley S, Fearon U, Veale D, Wilson AG & Muthana M (2013) . Annals of the Rheumatic Diseases, 72(Suppl 3), A199.1-A199.
• Albloui FS, Muthana M, Wilson AG & Grabowski PS (2013) . Annals of the Rheumatic Diseases, 72(Suppl 3), A812.2-A812.
• Hardy WJ, Aynsley S, Fearon U, Veale D, Wilson AG & Muthana M (2013) HYPDXIA-INDUCIBLE FACTOR 2A IS PREFERENTIALLY EXPRESSED BY M2-LIKE SYNOVIAL MACROPHAGES IN RHEUMATOID ARTHRITIS. ANNALS OF THE RHEUMATIC DISEASES, 72, 199-199.
• Hawtree S, Muthana M, Aynsley S, Wilkinson JM & Wilson AG (2013) THE ROLE OF HISTONE DEACETYLASES IN RHEUMATOID ARTHRITIS FIBROBLASTS-LIKE SYNOVIOCYTES. ANNALS OF THE RHEUMATIC DISEASES, 72, 165-166.
• Hawtree S, Muthana M & Wilson AG (2013) . Biochem Soc Trans, 41(3), 783-788.
• Mehta P, Holder S, Fisher B, Vincent T, Nadesalingam K, Maciver H, Shingler W, Bakshi J, Hassan S, D'Cruz D , Chan A et al (2013) . Rheumatology, 52(suppl 1), i56-i94.
• Fleischmann R, van Vollenhoven RF, Smolen J, Emery P, Florentinus S, Rathmann S, Kupper H, Kavanaugh A, Taylor P, Genovese M , Keystone EC et al (2013) . Rheumatology, 52(suppl 1), i44-i55.
• Muthana M, Richardson J, Rodrigues S & Lewis C (2013) . BIO-PROTOCOL, 3(13).
• Muthana M, Rodrigues S, Chen Y-Y, Welford A, Hughes R, Tazzyman S, Essand M, Morrow F & Lewis CE (2013) . Cancer Res, 73(2), 490-495.
• Murdoch C, Aziz HA, Fang H-Y, Jezan H, Musaid R & Muthana M (2011) . J Ethnopharmacol, 138(3), 780-787.
• Coffelt SB, Chen Y-Y, Muthana M, Welford AF, Tal AO, Scholz A, Plate KH, Reiss Y, Murdoch C, De Palma M & Lewis CE (2011) . J Immunol, 186(7), 4183-4190.
• Owen MR, Stamper IJ, Muthana M, Richardson GW, Dobson J, Lewis CE & Byrne HM (2011) . Cancer Res, 71(8), 2826-2837.
• Muthana M, Giannoudis A, Scott SD, Fang H-Y, Coffelt SB, Morrow FJ, Murdoch C, Burton J, Cross N, Burke B , Mistry R et al (2011) . Cancer Res, 71(5), 1805-1815.
• Muthana M, Multhoff G & Pockley AG (2010) . Int J Hyperthermia, 26(3), 247-255.
• Murdoch C, Muthana M, Coffelt SB & Lewis CE (2008) . Nat Rev Cancer, 8(8), 618-631.
• Muthana M, Scott SD, Farrow N, Morrow F, Murdoch C, Grubb S, Brown N, Dobson J & Lewis CE (2008) . Gene Ther, 15(12), 902-910.
• Pockley AG, Muthana M & Calderwood SK (2008) . Trends Biochem Sci, 33(2), 71-79.
• Pockley AG, Fairburn B, Mirza S, Slack LK, Hopkinson K & Muthana M (2007) . Methods, 43(3), 238-244.
• Slack LK, Muthana M, Hopkinson K, Suvarna SK, Espigares E, Mirza S, Fairburn B & Pockley AG (2007) . Cell Stress Chaperones, 12(1), 71-82.
• Fairburn B, Muthana M, Hopkinson K, Slack LK, Mirza S, Georgiou AS, Espigares E, Wong C & Pockley AG (2006) . Biochimie, 88(9), 1165-1174.
• Mirza S, Muthana M, Fairburn B, Slack LK, Hopkinson K & Pockley AG (2006) . Cell Stress Chaperones, 11(4), 364-378.
• Muthana M, Fairburn B, Mirza S, Slack LK, Hopkinson K & Pockley AG (2006) . Immunobiology, 211(5), 391-402.
• Muthana M, Slack LK, Hopkinson K, Espigares E, Fairburn B, Mirza S & Pockley AG (2005) Gp96 prolongs rat cardiac allograft survival and modifies rejection-associated inflammatory events. IMMUNOLOGY, 116, 107-107.
• Mirza S, Muthana M, Slack LK, Hopkinson K, Fairburn B & Pockley AG (2005) The stress protein gp96 does not activate rat bone marrow-derived dendritic cells. IMMUNOLOGY, 116, 98-98.
• Murdoch C, Muthana M & Lewis CE (2005) . J Immunol, 175(10), 6257-6263.
• Pockley AG & Muthana M (2005) . Contrib Nephrol, 148, 122-134.
• Muthana M, Fairburn B, Mirza S, Slack LK & Pockley AG (2004) . J Immunol Methods, 294(1-2), 165-179.
• Carlring J, Shaif-Muthana M, Sisley K, Rennie IG & Murray AK (2003) . Immunology, 109(1), 41-48.
• Molife R, Muthana M, Wilkinson D, Hedley S, Browne S, Brookes R, Murray A, Rennie I & Lorigan P (2002) Pilot study: Immunisation with melanoma associated peptides and GM-CSF in HLA-A2 patients with metastatic melanoma.. BRIT J CANCER, 86, S115-S115.
• Shaif-Muthana M, McIntyre C, Sisley K, Rennie I & Murray A (2000) Dead or alive: immunogenicity of human melanoma cells when presented by dendritic cells.. Cancer Res, 60(22), 6441-6447.
• Gao Z, Mansor MH, Howard F, MacInnes J, Zhao X & Muthana M () . Nanomaterials, 15(3), 221-221.
• Mansor MH, Gao Z, Howard F, MacInnes J, Zhao X & Muthana M () . Pharmaceutics, 17(1), 95-95.
• Kwan A, Mcdermott-Brown I & Muthana M () . Viruses, 16(8), 1264-1264.
• Gao Z, Mansor MH, Winder N, Demiral S, Maclnnes J, Zhao X & Muthana M () . Pharmaceutics, 15(7), 1811-1811.
• Winder N, Ashraf Z, Gohar S, Baalbaki N, Cork M, Danby S & Muthana M () . Frontiers in Virology, 3, 1180815.
• Tazzyman S, Stewart GR, Yeomans J, Linford A, Lath D, Conner J, Muthana M, Chantry AD & Lawson MA () . Viruses, 15(3), 603-603.
• Kwan A, Howard F, Winder N, Atkinson E, Jailani A, Patel PB, Allen R, Ottewell PD, Shaw GC, Conner J , Wilson C et al () . Future Pharmacology, 2(4), 444-459.
• Howard FHN, Kwan A, Winder N, Mughal A, Collado-Rojas C & Muthana M () . Viruses, 14(7), 1493-1493.
• Howard F, Conner J, Danson S & Muthana M () . Frontiers in Molecular Biosciences, 9.
• Kim T, Johnston J, Felipe FJC, Hamby S, Castillo-Lluva S, Goodall AH, Velasco G, Ocana A, Muthana M & Kiss-Toth E () .
• Murdoch C, Tazzyman S, Harrison J, Yeomans J & Muthana M () . Hypoxia, 185-185.
• Kwan A, Winder NJ, Atkinson E, Al-Janabi HH, Allen RJ, Hughes R, Moamin MR, Louie R, Evans D, Hutchinson M , Capper DT et al () . Molecular Cancer Therapeutics, molcanther.0748.2020-molcanther.0748.2020.

Chapters

• Nutter Howard FH, Iscaro A & Muthana M (2022) , Systemic Drug Delivery Strategies (pp. 211-230). Elsevier
• Hughes R & Muthana M (2014) , Tumor Immunology and Immunotherapy (pp. 43-62). Oxford University Press
• Hughes R, Fang H-Y, Muthana M & Lewis CE (2011) , Tumour-Associated Macrophages (pp. 17-29). Springer New York
• Pockley AG & Muthana M (2007) , Heat Shock Proteins: Potent Mediators of Inflammation and Immunity (pp. 309-320). Springer Netherlands
• Pockley AG & Muthana M (2007) , Cell Stress Proteins (pp. 377-395). Springer New York
• H.N. Howard F, Gao Z, Bin Mansor H, Yang Z & Muthana M () , Biomedical Engineering IntechOpen
• Iscaro A, H.N. Howard F, Yang Z, Jenkins F & Muthana M () , Liposomes - Recent Advances, New Perspectives and Applications [Working Title] IntechOpen

Conference proceedings papers

• Sheridan K, Doris E, Pimenta M, Falkov J, Fisher M, Muthana M, Shields D, Mains R, Eipper B, Buckley C & Wilson A (2024) Genetically Determined Peptidylglycine Alpha-amidating Monooxygenase (PAM) Mediated Amidation Regulates Tissue Damage by Rheumatoid Arthritis Synovial Fibroblasts. ARTHRITIS & RHEUMATOLOGY, Vol. 76 (pp 1864-1865)
• Rahman MM, Wells G, Rantala J, Helleday T, Muthana M & Danson S (2023) . Annals of Oncology, Vol. 34 (pp S1177-S1177)
• Al-janabi H, Pu X, Muthana M, Wang N, Crespo M, Gurel B, De Bono J, Brown JE & Lewis CE (2021) . Tumor Biology
• Al-Janabi H, Pu X, Muthana M, Wang N, Crespo M, Gurel B, De Bono J, Brown JE & Lewis CE (2021) Changes in the phenotype of macrophages and CD8+T Cells in the perivascular niche of prostate tumours following androgen deprivation.. CANCER RESEARCH, Vol. 81(13)
• Danson SJ, Conner J, Edwards JG, Blyth KG, Fisher PM, Muthana M, Salawu A, Taylor F, Hodgkinson E, Joyce P , Roman J et al (2020) . Lung Cancer
• AL-Janabi H, Conner J, Howard F, Hunt S, Taher Z, Staniland S & Muthana M (2019) . Immunology
• Pu X, AL-Janabi H, Wang N, Muthana M, Brown J & Lewis C (2019) . Tumor Biology
• Pu X, AL-Janabi H, Wang N, Muthana M, Brown J & Lewis C (2019) . Tumor Biology
• Moamin MR, Monk P, Cox A, Ottewell P, Saint-Pol J, Rubinstein E & Muthana M (2019) . Tumor Biology
• Moamin MR, Monk P, Cox A, Ottewell P, Saint-Pol J, Rubinstein E & Muthana M (2019) . Tumor Biology
• AL-Janabi H, Conner J, Howard F, Hunt S, Taher Z, Staniland S & Muthana M (2019) . Immunology
• Stewart G, Tazzyman ST, Lath D, Down J, Lawson M, Muthana M & Chantry A (2019) Myeloma-specific oncolytic adenovirus induces significant tumour oncolysis in vitro and in vivo and prevents cell line regrowth. BRITISH JOURNAL OF HAEMATOLOGY, Vol. 185 (pp 97-97)
• AL-Janabi H, Conner J, Taher Z, Staniland S & Muthana M (2018) . European Journal of Cancer, Vol. 92 (pp S4-S4)
• Seehra RS, Wharton S, Heath P, Ince P, Muthana M, Garwood C & Simpson J (2018) Hypoxia-induced changes in astrocytes and their role in the formation of age-associated white matter lesions. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, Vol. 44 (pp 17-18)
• Dorris E, Creevey K, Moylett J, Tazzyman S, Muthana M & Wilson AG (2017) The Rheumatoid Arthritis Susceptibility Gene C5orf30 Is an Immunomodulator in Macrophages. ARTHRITIS & RHEUMATOLOGY, Vol. 69
• Muthana M, Murphy E, Kwan A, Winder N & Conner J (2017) . Tumor Biology
• Dorris ER, Creevey K, Moran C, Muthana M & Wilson AG (2016) . Annals of the Rheumatic Diseases, Vol. 75(Suppl 2) (pp 107.1-107)
• Tazzyman S, Muthana M, Harrison J, Lewis C, Conner J & Chantry A (2015) . Journal of Clinical Oncology, Vol. 33(15_suppl) (pp e14035-e14035)
• Hardy W, Wright F, Hawtree S, Fearon U, Veale D, Perretti M, Wilson A & Muthana M (2014) . Annals of the Rheumatic Diseases, Vol. 73(Suppl 2) (pp 174.2-174)
• Muthana M, Davies H, Khetan S, Wright F, Hawtree S, Ciani B & Wilson A (2014) . Annals of the Rheumatic Diseases, Vol. 73(Suppl 2) (pp 361.3-361)
• Hawtree S, Muthana M, Wilkinson JM & Wilson AG (2014) . Annals of the Rheumatic Diseases, Vol. 73(Suppl 2) (pp 517.2-517)
• Muthana M, Khetan S, Hawtree S, Davies H, Gbadebo A, Akil M, Ciani B, Wright F & Wilson AG (2014) . Rheumatology, Vol. 53(suppl_1) (pp i147-i147)
• Hawtree S, Muthana M, Wilkinson JM & Wilson AG (2014) INVESTIGATION OF THE ROLE OF HISTONE DEACETYLASES IN RHEUMATOID ARTHRITIS SYNOVIAL FIBROBLASTS. RHEUMATOLOGY, Vol. 53 (pp 85-85)
• Muthana M, Khetan S, Hawtree S, Davies H, Gbadebo A, Akil M, Ciani B, Wright F & Wilson AG (2014) BIOLOGICAL ROLES OF C5ORF30 IN RHEUMATOID ARTHRITIS SYNOVIAL FIBROBLASTS. RHEUMATOLOGY, Vol. 53 (pp 147-147)
• Albloui FS, Muthana M, Wilson AG & Grabowski PS (2014) Acidification enhances acid sensing protein and matrix metalloproteinase expression in human rheumatoid fibroblast like synoviocytes. Annals of the Rheumatic Diseases, Vol. 73(Supplement 2) (pp 511-511)
• Davies H, Muthana M, Khetan S, Adeleke G, Hawtree S, Morrow F, Ciani B & Wilson AG (2013) . Annals of the Rheumatic Diseases, Vol. 72(Suppl 3) (pp A190.2-A190)
• Muthana M, Davies H, Khetan S, Adeleke G, Hawtree S, Wright F, Ciani B, Akil M & Wilson AG (2013) The biological role of C5orf30 in rheumatoid arthritis pathogenesis. IMMUNOLOGY, Vol. 140 (pp 45-45)
• Muthana M, Davies H, Khetan S, Adeleke GA, Hawtree S & Wilson AG (2013) Biological Roles of C5orf30 In Rheumatoid Arthritis Synovial Fibroblasts. ARTHRITIS AND RHEUMATISM, Vol. 65 (pp S1232-S1233)
• Hawtree S, Muthana M, Aynsley S, Wilkinson JM & Wilson AG (2013) Investigation Of The Role Of Histone Deacetylases In Rheumatoid Arthritis Synovial Fibroblasts. ARTHRITIS AND RHEUMATISM, Vol. 65 (pp S1035-S1036)
• Hawtree S, Muthana M, Aynsley S, Wilkinson JM & Wilson AG (2013) Investigation of the role of histone deacetylases in rheumatoid arthritis synovial fibroblasts. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, Vol. 94(5) (pp A3-A3)
• Albloui FS, Muthana M, Wilson AG & Grabowski PS (2013) TISSUE LOCALISATION OF ACID SENSING PROTEINS IN SYNOVIAL BIOPSIES FROM PATIENTS WITH RHEUMATOID ARTHRITIS. ANNALS OF THE RHEUMATIC DISEASES, Vol. 72 (pp 812-812)
• Davies H, Muthana M, Khetan S, Adeleke G, Hawtree S, Morrow F, Ciani B & Wilson AG (2013) THE ROLE OF C5ORF30 IN RHEUMATOID ARTHRITIS PATHOGENESIS. ANNALS OF THE RHEUMATIC DISEASES, Vol. 72 (pp 190-190)
• Muthana M, Davies H, Khetan S, Adeleke G, Hawtree S, Tazzyman S, Morrow F, Ciani B & Wilson G (2013) BIOLOGICAL ROLES OF C5ORF30 IN RHEUMATOID ARTHRITIS. RHEUMATOLOGY, Vol. 52 (pp 50-50)
• Hawtree S, Muthana M, Aynsley S, Wilkinson JM & Wilson AG (2013) INVESTIGATION OF THE ROLE OF HISTONE DEACETYLASES IN RHEUMATOID ARTHRITIS SYNOVIAL FIBROBLASTS. RHEUMATOLOGY, Vol. 52 (pp 79-80)
• Aynsley S, Hardy J, Veale D, Fearon U, Wilson G & Muthana M (2013) MACROPHAGES IN HYPOXIC RHEUMATOID JOINTS PREFERENTIALLY EXPRESS HYPOXIA-INDUCIBLE TRANSCRIPTION FACTOR-2. RHEUMATOLOGY, Vol. 52 (pp 78-78)
• Muthana M, Khetan S, Adeleke GA, Tazzyman S, Aynsley S, Morrow F, Hawtree S, Ciani B & Wilson AG (2012) Biological Roles of C5orf30 in Rheumatoid Arthritis. ARTHRITIS AND RHEUMATISM, Vol. 64(10) (pp S767-S767)
• Aynsley S, Fearon U, Wilson AG & Muthana M (2012) Macrophages in Hypoxic Rheumatoid Joints Preferentially Express Hypoxia Inducible Transcription Factor-2. ARTHRITIS AND RHEUMATISM, Vol. 64(10) (pp S767-S767)
• Grabowski PS, Muthana M & Wilson AG (2012) . BONE, Vol. 50 (pp S191-S191)
• Khetan S, Muthana M & Wilson AG (2011) C5orf30 a Candidate Susceptibility Gene in Rheumatoid Arthritis. ARTHRITIS AND RHEUMATISM, Vol. 63(10) (pp S719-S719)
• Muthana M, Giannoudis A, Scott SD, Mistry R, Murdoch C, Coffelt S, Georgeopolous L, Hamdy F, Brown N, Maitland N & Lewis CE (2010) . DRUG DISCOVERY TODAY, Vol. 15(23-24) (pp 1097-1098)
• Muthana M, Giannoudis A, Scott SD, Mistry R, Murdoch C, Georgeopolous L, Hamdy F, Brown N, Maitland N & Lewis CE (2010) Engineering Macrophages to Synthesize Recombinant Adenoviruses in Hypoxic Areas of Human Prostate Tumours. HUMAN GENE THERAPY, Vol. 21(4) (pp 488-488)
• Muthana M, Scott S, Farrow N, Murdoch C & Lewis C (2007) Magnetite nanoparticle-loaded macrophages enhance gene delivery to tumours. IMMUNOLOGY, Vol. 120 (pp 82-82)
• Muthana M, Giannoudis A, Scott SD, Burke B, Mistry R, Hamdy F, Brown N, Maitland N & Lewis CE (2006) Engineering macrophages to synthesize recombinant adenoviruses in hypoxic areas of human prostate tumors. CANCER RESEARCH, Vol. 66(8)

Other

• Kwan A, Winder N, Atkinson E, Al-Janabi H, Allen RJ, Hughes R, Moamin M, Louie R, Evans D, Hutchinson M , Capper D et al (2023) .
• Kwan A, Winder N, Atkinson E, Al-Janabi H, Allen RJ, Hughes R, Moamin M, Louie R, Evans D, Hutchinson M , Capper D et al (2023) .
• Kwan A, Winder N, Atkinson E, Al-Janabi H, Allen RJ, Hughes R, Moamin M, Louie R, Evans D, Hutchinson M , Capper D et al (2023) .
• Kwan A, Winder N, Atkinson E, Al-Janabi H, Allen RJ, Hughes R, Moamin M, Louie R, Evans D, Hutchinson M , Capper D et al (2023) .

Preprints

• Al-janabi H, Moyes K, Allen R, Fisher M, Crespo M, Gurel B, Rescigno P, De Bono J, Nunns H, Bailey C , Juncker-Jensen A et al (2024) , Cold Spring Harbor Laboratory.